difference between tirzepatide vs semaglutide Semaglutide: Weight Loss, Side Effects, Uses Tirzepatide vs. semaglutide for weight

Timeline of How GLP-1s Work: Week 1-2: Medication reaches therapeutic levels Begin noticing reduced appetite Food sounds less appealing Easier to stop eating when satisfied Week 3-4: Appetite suppression more pronounced Portions naturally smaller Less frequent eating First measurable weight loss (3-5 pounds) Week 5-12: Steady appetite control Consistent portion reduction Weight loss accelerates (1-2 pounds weekly) Side effects typically improving Month 4-6: Dose increases continue (if tolerating well) Sustained weight loss (10-15 pounds total) New eating habits feeling normal Significant results becoming visible Month 7-12: Approaching or reaching maintenance dose Steady continued weight loss Total loss: 15-30 pounds depending on starting weight Metabolic improvements evident in lab work Month 13-20: Maximum weight loss achieved Average 10-22% total body weight lost Maintenance phase begins Focus shifts to sustaining results What GLP-1s DONT Do: Common Misconceptions: They dont: Burn fat directly like thermogenic supplements Block calorie absorption like fat blockers Speed up metabolism dramatically Work without you eating less (you eat less naturally) Cure obesity (stopping leads to weight regain) Eliminate need for healthy habits They do: Make eating less feel natural and sustainable Reduce biological hunger signals Help you consume fewer calories without constant struggle Provide biological support for behavioral changes Treat obesity as the chronic condition it is Why GLP-1s Succeed Where Other Approaches Fail: The Biological Barrier: When you lose weight through calorie restriction alone: Your body produces more hunger hormone (ghrelin) Satiety hormones (leptin, GLP-1) decrease Metabolism slows by 15-20% Cravings intensify Your body fights to regain weight This is why 80-95% of people who lose weight through diet alone regain it

Bupropion acts on neurotransmitters in the hypothalamus to regulate appetite, while naltrexone blocks pleasure receptors in the brain, says Dr

It found no evidence that exenatide slowed progression, and dopamine-transporter SPECT imaging in the trials substudy showed no treatment difference [2]

Instead, it provides some support for antioxidant pathways

GLP-1 prompts the body to produce more insulin, which reduces blood glucose and in conjunction with diet and exercise treats Type 2 diabetes